Library Board approves collections and content development strategic plan

first_imgThe Harvard Library Board recently approved recommendations outlined in “Towards a Collections and Content Development Strategic Plan for the Harvard Library,” fulfilling key recommendations of both the Task Force on the Harvard Libraries and the Library Implementation Working Group.Collections and content development will remain in the domain of the local or School libraries, with librarians, curators, archivists and faculty throughout the University broadly coordinating efforts in a more structured and deliberate way. Producing the final report for the board’s approval was the responsibility of the Affinity Group heads, working with the executive director for the Harvard Library, following extensive consultation with Library staff members, faculty, researchers and other key stakeholders. Feedback on interim reports was gathered from working groups, community-wide discussion sessions, Affinity Group meetings, online fora, one-on-one meetings and members of the Library Board and Faculty Advisory Council. Comments were gathered and assessed, then incorporated into the final report.Helen Shenton, executive director for the Harvard Library, said, “With a University-wide collection development strategic plan in place, the Library is positioned to support the changing needs of Harvard’s scholars in an even more robust way. It has been a privilege to help steer this inaugural Harvard Library strategy to unanimous approval by the Harvard Library Board. I am enormously proud of the way the Affinity Group heads worked together to produce this well-written and nuanced report, and look forward to seeing the recommendations implemented.” Read Full Storylast_img read more

H1N1 FLU BREAKING NEWS: Vaccine news, Microsoft’s online tool

first_img Microsoft offers online flu self-assessmentMicrosoft launched a new Web site today, H1N1 Swine Flu Response Center, to help patients assess flu-like symptoms and decide their next step. The self-assessment is licensed from experts at Emory University. Dr. Arthur Kellermann, professor of emergency medicine at Emory, said in a Microsoft release that the tool “can encourage those who are severely ill or at risk for serious illness to contact their doctor, and reassure everyone else that it is safe and prudent to recover at home.”http://www.microsoft.com/presspass/press/2009/oct09/10-07h1n1responsecenterpr.mspxOct 7 Microsoft news release EU approves Baxter’s cell-based vaccineThe European Commission today approved Baxter International’s pandemic H1N1 vaccine, Celvapan, for use in the European Union, the company announced. It is the first cell culture-based H1N1 vaccine as well as the first non-adjuvanted product to win European approval. The EU authorization calls for using two doses of the vaccine in adults and children; the company is awaiting trial results to determine if one dose will be sufficient in adults.http://www.baxter.com/press_room/press_releases/2009/10_07_09-celvapan.htmlOct 7 Baxter news release Oct 7, 2009 Study: Seasonal vaccine may help fight H1N1Contrary to most other evidence, a study from Mexico suggests that seasonal flu vaccine may offer some protection against the novel H1N1 virus. Researchers compared the vaccination status of 60 H1N1 case-patients and 180 control patients at a specialty hospital. The H1N1 patients were less likely to have had a seasonal flu shot. But the authors say the study is limited by its small size, retrospective design, and the high prevalence of vaccination and chronic conditions in the control group.http://www.bmj.com/cgi/content/full/339/oct06_2/b3928Oct 6 British Medical Journal study Novartis ships seasonal, H1N1 vaccines to USVaccine manufacturer Novartis said yesterday it has completed shipments of its seasonal flu vaccine, Fluvirin, to the United States after delivering 27 million doses. The Swiss company originally had said it planned to supply about 30 million doses to the US market. Yesterday the firm also said it started shipping swine flu vaccine on Sept. 27, 2 weeks after the formulation received approval from the US Food and Drug Administration.http://www.novartis.com/newsroom/media-releases/en/2009/1345850.shtmlOct 6 Novartis press releaselast_img read more

Uganda’s Flavia Namakula targets fourth golf championship title

first_imgSome of Africa’s best female golfers have descended on Uganda’s capital Kampala for the 2015 Uganda Ladies Golf Open. Defending champion Flavia Namakula hopes to make home advantage count as she bids to claim a fourth title. CCTV’s Leon Ssenyange reports.last_img